Journal of Multiple Sclerosis and Neuroimmunology

Previous issues

Page Path

HOME
BROWSE ARTICLES
Previous issue

Volume 13(2); Dec 2022

Review Article

자가면역결절병증: 유현지, 신하영; J Mult Scler Neuroimmunol. 2022;13(2):23-29. Published online December 31, 2022; PDF

Case Reports

리툭시맙 치료로 호전된 재발 중추신경계원발혈관염 1예: 김태영, 김용진, 김민, 전재현, 박현미, 신동훈, 양지원; J Mult Scler Neuroimmunol. 2022;13(2):30-34. Published online December 31, 2022; PDF

고용량 스테로이드로 치료한 무증상 COVID-19 감염 이후 파킨슨증: 강유진, 구가은, 추이슬, 원문호, 박찬영; J Mult Scler Neuroimmunol. 2022;13(2):35-38. Published online December 31, 2022; PDF

Neuroimage

ANCA관련혈관염 환자에서 일측성으로 우세하게 나타난 경수막염: 성의현, 김영서; J Mult Scler Neuroimmunol. 2022;13(2):39-40. Published online December 31, 2022; PDF

Volume 13, No. 2

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

6,015	Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
2,666	Rituximab Treatment for Neuroimmunologic Disorders
2,372	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
2,334	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
2,216	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review

Cited By
2

Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: icandr@cau.ac.kr

Copyright © 2024 by Korean Society of Neuroimmunology.